ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,509.31
      1.02%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. BiondVax Pharmaceuticals Ltd (BVXV)

      7. BiondVax Pharmaceuticals Ltd (BVXV) News

      BVXV

      BiondVax Pharmaceuticals (BVXV)

      BiondVax Pharmaceuticals Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BVXV
      DateTimeSourceHeadlineSymbolCompany
      12/27/20216:38AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      12/23/20218:01PMPR Newswire (US)BiondVax Announces Proposed Underwritten Public Offering of American Depositary SharesNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      12/22/20214:15PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      12/22/20217:07AMPR Newswire (US)BiondVax signs definitive agreements for development and commercialization of innovative nanosized COVID-19 antibody therapy with Max Planck Institute of Biophysical Chemistry and University Medical Center Göttingen, GermanyNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      12/13/20217:35AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      12/02/20214:15PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      11/30/20217:05AMPR Newswire (US)BiondVax announces Third Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      11/24/20213:07PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      11/24/20211:46PMPR Newswire (US)BiondVax Announces Notice of Annual General Meeting of Shareholders and Provides a Business UpdateNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      11/22/20216:06AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      11/15/20215:15AMPR Newswire (US)BiondVax to Present at H.C. Wainwright 7th Annual Israel ConferenceNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      11/12/20218:23AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      10/25/20216:05AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      10/19/20217:53AMPR Newswire (US)BiondVax advances its growth strategy towards a new pipeline based on innovative VHH antibodiesNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      08/26/20214:05PMPR Newswire (US)BiondVax Announces Second Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      06/23/20216:00AMPR Newswire (US)BiondVax Announces First Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      05/13/20214:54PMPR Newswire (US)BiondVax Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      03/23/20217:54AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      03/23/20217:44AMPR Newswire (US)Letter from BiondVax's New CEO to ShareholdersNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      03/22/20213:44PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      03/16/202111:17AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      03/04/20211:02PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      02/24/20214:58PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      02/17/20214:43PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      02/11/20216:31AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      02/10/20214:30PMPR Newswire (US)BiondVax Announces Exercise in Full of Underwriter's Over-Allotment Option in Follow-on OfferingNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      02/09/20216:07AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      02/08/20212:55PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      02/02/20214:37PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      02/02/20214:30PMPR Newswire (US)BiondVax Announces Closing of $12.1 Million Follow-on Underwritten OfferingNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
       Showing the most relevant articles for your search:NASDAQ:BVXV

      Your Recent History

      BIT
      S28673
      Societe Generale Effekten
      Delayed Upgrade Clock